These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7539517)

  • 1. Detection of minimal residual disease by reverse transcriptase polymerase chain reaction for the PML/RAR alpha fusion mRNA: a study in patients with acute promyelocytic leukemia following peripheral stem cell transplantation.
    Takatsuki H; Umemura T; Sadamura S; Yamashita S; Goto T; Abe Y; Yufu Y; Inaba S; Nishimura J; Nawata H
    Leukemia; 1995 May; 9(5):889-92. PubMed ID: 7539517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of the PML/RAR alpha rearrangement in acute promyelocytic leukemia using a reverse PCR method].
    Barragán E; Bonanad S; López JA; Martín G; Martínez J; Sanz GF; Gomis F; Pérez ML; Senent ML; Larrea L; Bolufer P; Sanz MA
    Sangre (Barc); 1996 Jun; 41(3):189-94. PubMed ID: 8755206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of distinct PML-RAR-alpha fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction.
    Chen SJ; Chen Z; Chen A; Tong JH; Dong S; Wang ZY; Waxman S; Zelent A
    Oncogene; 1992 Jun; 7(6):1223-32. PubMed ID: 1375719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PML/RAR alpha fusion gene in the diagnosis and monitoring of acute promyelocytic leukemia.
    Diverio D; Riccioni R; Mandelli F; Lo Coco F
    Haematologica; 1995; 80(2):155-60. PubMed ID: 7628753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and follow-up of acute promyelocytic leukemia by detection of PML-RAR alpha gene rearrangement.
    Gau JP; Young JH; Lin TH; Yang YS
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):175-81. PubMed ID: 10746412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients.
    Gameiro P; Vieira S; Carrara P; Silva AL; Diamond J; Botelho de Sousa A; Mehta AB; Prentice HG; Guimarães JE; Hoffbrand AV; Foroni L; Parreira A
    Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PML/RAR alpha transcripts monitored by polymerase chain reaction in acute promyelocytic leukemia during complete remission, relapse and after bone marrow transplantation.
    Perego RA; Marenco P; Bianchi C; Cairoli R; Urbano M; Nosari AM; Muti G; Morra E; Del Monte U
    Leukemia; 1996 Feb; 10(2):207-12. PubMed ID: 8637228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of peripheral blood progenitor cells demonstrates limitations of minimal residual disease diagnosis in a case of acute promyelocytic leukemia.
    Karlic HI; Mühlberger H; Pavlova BG; Pfeilstöcker M; Salamon J; Pittermann E; Heinz R; Koller E
    Bone Marrow Transplant; 1995 Jun; 15(6):999-1000. PubMed ID: 7581106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of detectable PML-RAR alpha fusion transcripts in long-term remission patients after BMT for acute promyelocytic leukemia.
    Román J; Martín C; Torres A; Jiménez MA; Andrés P; Flores R; de la Torre MJ; Sánchez J; Serrano J; Falcón M
    Bone Marrow Transplant; 1997 Apr; 19(7):679-83. PubMed ID: 9156244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of RAR alpha-PML fusion mRNA detected by reverse transcriptase polymerase chain reaction in patients in long-term remission of acute promyelocytic leukaemia.
    Tobal K; Saunders MJ; Grey MR; Yin JA
    Br J Haematol; 1995 Jul; 90(3):615-8. PubMed ID: 7647002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverse transcription-polymerase chain reaction for PML-RAR alpha fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection.
    Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
    Leukemia; 1993 Apr; 7(4):544-8. PubMed ID: 8385249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PML-RAR alpha fusion transcripts by RNA PCR in acute promyelocytic leukemia in remission and its correlation with clinical outcome.
    Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
    Int J Hematol; 1994 Oct; 60(3):197-205. PubMed ID: 7858239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion gene.
    Meloni G; Diverio D; Vignetti M; Avvisati G; Capria S; Petti MC; Mandelli F; Lo Coco F
    Blood; 1997 Aug; 90(3):1321-5. PubMed ID: 9242568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemia.
    Jurcic JG; Nimer SD; Scheinberg DA; DeBlasio T; Warrell RP; Miller WH
    Blood; 2001 Nov; 98(9):2651-6. PubMed ID: 11675334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapse.
    Grimwade D; Howe K; Langabeer S; Burnett A; Goldstone A; Solomon E
    Leukemia; 1996 Jan; 10(1):61-6. PubMed ID: 8558940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia.
    Miller WH; Kakizuka A; Frankel SR; Warrell RP; DeBlasio A; Levine K; Evans RM; Dmitrovsky E
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2694-8. PubMed ID: 1372989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
    Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
    Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged molecular remission after PML/RAR alpha-positive autologous peripheral blood stem cell transplantation in acute promyelocytic leukemia: is relevant pretransplant minimal residual disease in the graft?
    Sanz MA; de la Rubia J; Bonanad S; Barragán E; Sempere A; Martín G; Martínez JA; Jiménez C; Cervera J; Bolufer P; Sanz GF
    Leukemia; 1998 Jun; 12(6):992-5. PubMed ID: 9639431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pilot study of PML/RAR alpha fusion by fluorescence in situ hybridization (FISH)method in acute promyelocyte leukemia].
    Legües ME; Franco G; Bertin P
    Rev Med Chil; 2002 Jul; 130(7):737-44. PubMed ID: 12235897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse transcription polymerase chain reaction for the diagnosis and molecular monitoring of the PML/RAR alpha fusion gene in acute promyelocytic leukemia.
    Viniou NA; Yataganas X; Stamatopoulos K; Xefteri I; Kalmantis T; Papasavas P; Mitsulis C; Rombos J; Meletis J; Bourantas K
    Cancer Genet Cytogenet; 1995 Oct; 84(2):91-4. PubMed ID: 8536228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.